Back to search results
NCT03544983

Genetic Education in BRCA Families

Enrolling by Invitation
NAAges 21–75InterventionalHealth services
Georgetown University
~240 participants
Updated 2025-10-29 on ClinicalTrials.gov
What's tested:Web + Streamlined Telephone Genetic Information

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Uptake of genetic counseling and testing
Measured over 6-months post randomization

Conditions

BRCA1 Mutation
BRCA2 Mutation

Explore related trials

Breast CarcinomaMalignant Ovarian NeoplasmProstate CarcinomaBRCA1 GeneBRCA2 Gene

NCT03544983

Where you'd take part

This study runs at 4 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Dana Farber Cancer Institute

    Boston, Massachusettsno site contact published

  • Geisinger Medical Center

    Danville, Pennsylvaniano site contact published

  • George Washington University

    Washington D.C., District of Columbiano site contact published

  • Georgetown University Medical Center/Lombardi Comprehensive Cancer Center

    Washington D.C., District of Columbiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Marc D Schwartz, PhD · PRINCIPAL_INVESTIGATOR · Georgetown University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

A first- (sibling, adult offspring) or second-degree (aunt/uncle, niece/nephew if at-risk parent is deceased) biological relative of an individual with a recently identified BRCA1 or BRCA2 mutation

Exclusion

Personal diagnosis of metastatic cancer
Prior genetic testing for hereditary breast/ovarian cancer
Have one or more children who have tested positive for a BRCA1 or BRCA2 mutation
Cannot participate in or understand English
Cannot provide meaningful informed consent

What this trial measures

  • Uptake of genetic counseling and testing6-months post randomization

    The proportion of participants who complete genetic counseling and testing